YB-1 promotes laryngeal squamous cell carcinoma progression by inducing miR-155 expression via c-Myb

被引:23
作者
Zhao, Xudong [1 ]
Zhang, Wei [2 ]
Ji, Wenyue [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Otorhinolaryngol, Shenyang 110004, Liaoning, Peoples R China
[2] China Med Univ, Dept Endocrinol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
cervical metastasis; c-Myb; head and neck cancer; invasion; laryngeal cancer; LSCC; miR-155; prognosis; proliferation; YB-1; BINDING-PROTEINS; DIAGNOSIS; REGION;
D O I
10.2217/fon-2018-0058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: In this study, we investigated the role of Y-box binding protein-1 (YB- 1), c-Myb and miR-155 in human laryngeal squamous cell carcinoma (LSCC) progression. Materials & methods: Quantitative real-time PCR, western blot, MTT and Transwell were conducted to determine the expression and function of YB-1/ miR-155 pathway. Univariate and multivariate analyses were used to determine the prognostic factors. Results: Expression of YB-1, c-Myb and miR-155 was higher in LSCC tissues. YB-1 promoted proliferation, invasiveness and migration of Hep-2 cells in vitro. Patients with higher YB-1 correlated with advanced T stage, poor differentiation and cervical metastasis. LSCC patients with high YB-1 expression showed poor overall survival. Conclusion: YB-1 promotes LSCC progression by increasing miR-155 levels via c-Myb and acts as a prognostic factor.
引用
收藏
页码:1579 / 1589
页数:11
相关论文
共 25 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   PROTEIN TIGHTLY BOUND TO GLOBIN MESSENGER-RNA [J].
BLOBEL, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1972, 47 (01) :88-&
[3]   Laryngeal cancer: Diagnosis and preoperative work-up [J].
Chu, Eugene A. ;
Kim, Young J. .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2008, 41 (04) :673-+
[4]   CHARACTERIZATION OF THE CDNA-ENCODING A PROTEIN-BINDING TO THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II Y-BOX [J].
DIDIER, DK ;
SCHIFFENBAUER, J ;
WOULFE, SL ;
ZACHEIS, M ;
SCHWARTZ, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) :7322-7326
[5]   MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status [J].
Faraoni, Isabella ;
Laterza, Serena ;
Ardiri, Davide ;
Ciardi, Claudia ;
Fazi, Francesco ;
Lo-Coco, Francesco .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
[6]  
Ge WS, 2016, AM J TRANSL RES, V8, P3903
[7]   Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer [J].
Gessner, C ;
Woischwill, C ;
Schumacher, A ;
Liebers, U ;
Kuhn, H ;
Stiehl, P ;
Jürchott, K ;
Royer, HD ;
Witt, C ;
Wolff, G .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (01) :14-19
[8]   YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression [J].
Jürchott, K ;
Bergmann, S ;
Stein, U ;
Walther, W ;
Janz, M ;
Manni, I ;
Piaggio, G ;
Fietze, E ;
Dietel, M ;
Royer, HD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) :27988-27996
[9]   A ROLE FOR Y-BOX PROTEINS IN CELL-PROLIFERATION [J].
LADOMERY, M ;
SOMMERVILLE, J .
BIOESSAYS, 1995, 17 (01) :9-11
[10]   YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis [J].
Lovett, David H. ;
Cheng, Sunfa ;
Cape, Leslie ;
Pollock, Allan S. ;
Mertens, Peter R. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 398 (03) :482-488